Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is expanding its U.S. FDA-registered commercial manufacturing facility in San Diego by adding upstream and downstream GMP processing capabilities to meet increasing demand for 2000L scale single-use biologics manufacturing. The expansion adds 8,075 square feet of GMP manufacturing space to the San Diego biologics manufacturing facility, comprising an upstream mammalian ce...